# Advisor Review - Gemini-3-Flash

**Role:** Academic advisor checking for fatal errors
**Model:** gemini-3-flash-preview
**Paper:** paper.pdf
**Timestamp:** 2026-02-04T00:46:37.237135
**Route:** Direct Google API + PDF
**Tokens:** 31838 in / 624 out
**Response SHA256:** aa32f1d61c6dbebc

---

I have reviewed the draft paper "State Insulin Copay Cap Laws and Diabetes Mortality: A Difference-in-Differences Analysis" for fatal errors.

### **1. DATA-DESIGN ALIGNMENT**
*   **Treatment timing vs data coverage:** The paper identifies the latest data year as 2023 (Abstract, Section 4.5). It correctly identifies eight states with treatment onset in 2024–2025 (Georgia, Louisiana, Montana, Nebraska, North Carolina, Ohio, Wyoming, Indiana) and reclassifies them as "not-yet-treated" (Section 4.1, Table 3, Table 13). 
*   **Post-treatment observations:** The analysis correctly restricts the "effectively treated" sample to the seventeen states with treatment onset by 2023 for which post-treatment outcome data are available.
*   **Consistency:** Table 3 (policy timing) and Table 13 (cohort assignments) are consistent.

### **2. REGRESSION SANITY**
*   **Standard Errors:** Table 4 shows standard errors for mortality rates (per 100k) ranging from 1.365 to 1.963. These are reasonable for an outcome with a mean of ~24.
*   **Coefficients:** Log outcome coefficients (Table 4, Column 3) are < 1, which is typical. Levels coefficients are within a narrow range (-0.2 to 1.2), consistent with the scale of the outcome.
*   **Impossible Values:** R² and Adjusted R² values in Tables 4 and 6 are between 0 and 1. No "NA" or "Inf" values appear in results tables.

### **3. COMPLETENESS**
*   **Placeholder values:** No "TBD", "TODO", or "XXX" strings were found.
*   **Missing elements:** Regression tables (Table 4, Table 6, Table 14) report observation counts (Num.Obs.). Standard errors are provided in parentheses.
*   **Figures/Tables:** All referenced figures and tables (including those in the appendix) are present and numbered correctly.

### **4. INTERNAL CONSISTENCY**
*   **Numbers match:** The Abstract and text (Section 6.2) cite the Callaway-Sant'Anna aggregate ATT as 1.524. This matches Table 5 and Table 12.
*   **Sample sizes:** Table 1 provides a detailed reconciliation of the sample construction (1,157 observations), which is consistently used across Table 2, Table 4, Table 10, and Table 11.
*   **Cohort sizes:** Table 13 lists the number of states per cohort (e.g., 2021 cohort = 11 states), matching the adoption timeline in Figure 1.

**ADVISOR VERDICT: PASS**